Celeste Thomas to Hypoglycemic Agents
This is a "connection" page, showing publications Celeste Thomas has written about Hypoglycemic Agents.
Connection Strength
0.114
-
Metformin nephrotoxicity insights: will they change clinical management? J Diabetes. 2014 Mar; 6(2):111-2.
Score: 0.080
-
The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis. J Gen Intern Med. 2022 02; 37(2):415-438.
Score: 0.034